Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06785207 · ClinicalTrials.gov registry record · NA
Rethinking Rigidity: Development of a 3D-Printed Scoliosis Brace With Varying Flexibility
A NA study of Scoliosis Idiopathic Adolescent Treatment, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 2
- Study locations
NCT06785207: Recruiting NA study of Scoliosis Idiopathic Adolescent Treatment, sponsored by Baylor College of Medicine.
NCT06785207 is a NA study of Scoliosis Idiopathic Adolescent Treatment that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06785207, a NA study of Scoliosis Idiopathic Adolescent Treatment, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 2
- Study locations
Study Summary
Scoliosis bracing is an effective treatment method for idiopathic scoliosis, but only if worn consistently for many hours a day. Unsurprisingly, brace discomfort is a significant deterrent against treatment adherence. For decades, custom braces for idiopathic scoliosis have been fabricated using one of three materials - copolymer, polypropylene, or polyethylene. The application of the biomechanical principles behind bracing have improved over the years, but the materials have not. The investigators' goal is to expand fabrication options by testing a 3D-printed scoliosis brace with variable flexibility. The aim is to improve patients' perceived brace comfort. After optimizing the brace design, the investigators will collect patient feedback about the design from currently braced participants. These participants understand what a standard brace feels like and will provide impactful feedback.
Primary Outcome
Participants will complete a series of tasks (sitting down, putting shoes on, stepping onto stool, etc.) in their current brace and in the 3D-printed scoliosis brace. Each task will be completed three times and researchers will be blinded to participant responses. A Wilcoxon signed-rank test will compare 3D printed brace comfort to baseline measures.
Conditions Studied
Interventions
- DEVICE 3D-printed scoliosis brace
Study Locations (2)
Texas
- University of Texas Health Science Center at Houston - Houston
- Align Clinic - The Woodlands
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT06785207 shows while recruiting
NCT06785207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Scoliosis Idiopathic Adolescent Treatment appearing as the primary indexed condition, and to 1 intervention - of which 3D-printed scoliosis brace is the first listed.
NCT06785207 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06785207 about?
NCT06785207 is a clinical study titled "Rethinking Rigidity: Development of a 3D-Printed Scoliosis Brace With Varying Flexibility". Scoliosis bracing is an effective treatment method for idiopathic scoliosis, but only if worn consistently for many hours a day. Unsurprisingly, brace discomfort is a significant deterrent against treatment adherence. For decades, custom braces for idiopathic scoliosis have been fabricated using one...
What is the current status of trial NCT06785207?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-04-01. Estimated completion is 2025-12-31.
What conditions does trial NCT06785207 study?
This clinical trial studies the following conditions: Scoliosis Idiopathic Adolescent Treatment.
What interventions are being tested in trial NCT06785207?
The interventions under investigation include: 3D-printed scoliosis brace (DEVICE).
Who is sponsoring clinical trial NCT06785207?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06785207 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scoliosis Idiopathic Adolescent Treatment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06785207's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI